| MDMA | Q69488 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0014-2999(00)00749-4 |
| P698 | PubMed publication ID | 11070182 |
| P50 | author | Kirsten Morley | Q57072925 |
| P2093 | author name string | I S McGregor | |
| K C Morley | |||
| P2860 | cites work | Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat | Q29619517 |
| Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines | Q34246061 | ||
| Activation of 5-HT2B receptors in the medial amygdala causes anxiolysis in the social interaction test in the rat. | Q34432759 | ||
| Antipsychotic agents antagonize non-competitive N-methyl-D-aspartate antagonist-induced behaviors | Q36670129 | ||
| Recreational MDMA use in Sydney: a profile of 'Ecstacy' users and their experiences with the drug | Q38555431 | ||
| Attack and defense in rodents as ethoexperimental models for the study of emotion | Q38760409 | ||
| 5HT drugs in animal models of anxiety | Q40601511 | ||
| Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy") | Q41110153 | ||
| The anxiogenic-like and anxiolytic-like effects of MDMA on mice in the elevated plus-maze: a comparison with amphetamine | Q42595162 | ||
| The use of social interaction as a method for detecting anxiolytic activity of chlordiazepoxide-like drugs | Q42664406 | ||
| Antagonism of meta-chlorophenylpiperazine-induced inhibition of exploratory activity in an emergence procedure, the open field test, in rats. | Q42687030 | ||
| Phenomenology and sequelae of 3,4-methylenedioxymethamphetamine use | Q46423477 | ||
| Incidence of recreational use of 3,4-methylenedimethoxymethamphetamine (MDMA, "ecstasy") on an undergraduate campus | Q46496523 | ||
| The effects of amperozide on cocaine-induced social withdrawal in rats | Q48097076 | ||
| The distribution of 3,4-methylenedioxymethamphetamine "Ecstasy"-induced c-fos expression in rat brain | Q48149811 | ||
| Habituation and generalization of phobic responses to cat odor | Q48197301 | ||
| Intracranial self-stimulation under a progressive-ratio schedule in rats: effects of strength of stimulation, d-amphetamine, 7-OH-DPAT and haloperidol | Q48234586 | ||
| MDMA elicits behavioral and neurochemical sensitization in rats | Q48478397 | ||
| Animal models for predicting clinical efficacy of anxiolytic drugs: social behaviour | Q48583993 | ||
| Effect of 5-HT1A receptor agonists in two models of anxiety after dorsal raphe injection | Q48594691 | ||
| Psychological and cardiovascular effects and short-term sequelae of MDMA ("ecstasy") in MDMA-naïve healthy volunteers | Q48788983 | ||
| Anxiogenic properties of cocaine in the rat evaluated with the elevated plus-maze | Q48828409 | ||
| Behavioral, physiological and neuroendocrine responses in healthy volunteers to m-chlorophenylpiperazine (m-CPP) with and without ondansetron pretreatment. | Q51105440 | ||
| MDMA ("ecstasy") and panic disorder: induction by a single dose | Q51147500 | ||
| Subjective reports of the effects of MDMA in a clinical setting. | Q51207935 | ||
| Pharmacological characterisation of a modified social interaction model of anxiety in the rat. | Q51228042 | ||
| Self-administration of cocaine analogs by rats. | Q51447524 | ||
| Low-dose midazolam attenuates predatory odor avoidance in rats. | Q51475770 | ||
| A new approach to the light/dark test procedure in mice. | Q51508703 | ||
| Serotonergic modulation of 3,4-methylenedioxymethamphetamine (MDMA)-elicited reduction of response rate but not rewarding threshold in accumbal self-stimulation. | Q52196710 | ||
| Aversive effects of the synthetic cannabinoid CP 55,940 in rats. | Q52202419 | ||
| Reinforcing effects of certain serotonin-releasing amphetamine derivatives. | Q52203594 | ||
| Conditioned ultrasonic distress vocalizations in adult male rats as a behavioural paradigm for screening anti-panic drugs. | Q52211597 | ||
| Psychomotor stimulant effects of d-amphetamine, MDMA and PCP: aggressive and schedule-controlled behavior in mice. | Q52216022 | ||
| Ecstasy use in Australia: patterns of use and associated harm | Q60630740 | ||
| The antinociceptive effects of 3,4-methylenedioxymethamphetamine (MDMA) in the rat | Q69378649 | ||
| Anxiolytic effect of the 5-HT1A compounds 8-hydroxy-2-(di-n-propylamino) tetralin and ipsapirone in the social interaction paradigm: evidence of a presynaptic action | Q71861870 | ||
| Shock-induced ultrasonic vocalization in young adult rats: a model for testing putative anti-anxiety drugs | Q72664427 | ||
| MDMA (Ecstasy) neurotoxicity: assessing and communicating the risks | Q73837153 | ||
| Panic disorder induced by large doses of 3,4-methylenedioxymethamphetamine resolved by paroxetine | Q74212259 | ||
| Effects of continuous D-amphetamine and phencyclidine administration on social behaviour, stereotyped behaviour, and locomotor activity in rats | Q74603433 | ||
| Behavioral profile of 3,4-methylenedioxy-methamphetamine (MDMA) in agonistic encounters between male mice | Q77882072 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | social interaction | Q609298 |
| P304 | page(s) | 41-49 | |
| P577 | publication date | 2000-11-01 | |
| P1433 | published in | European Journal of Pharmacology | Q1376712 |
| P1476 | title | (+/-)-3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') increases social interaction in rats. | |
| P478 | volume | 408 |
| Q34021568 | 'Ecstasy' as a social drug: MDMA preferentially affects responses to emotional stimuli with social content. |
| Q47777762 | (±)-MDMA and its enantiomers: potential therapeutic advantages of R(-)-MDMA. |
| Q35851128 | A developmental comparison of the neurobehavioral effects of ecstasy (MDMA) |
| Q44070534 | Acute and carryover effects in mice of MDMA ("ecstasy") administration during periadolescence |
| Q36102552 | Acute and constitutive increases in central serotonin levels reduce social play behaviour in peri-adolescent rats. |
| Q44885616 | Acute and long-term consequences of single MDMA administration in relation to individual anxiety levels in the rat. |
| Q44229679 | Acute and subchronic effects of MDMA ("ecstasy") on anxiety in male mice tested in the elevated plus-maze. |
| Q64087722 | Aromatic Bromination Abolishes the Psychomotor Features and Pro-social Responses of MDMA ("Ecstasy") in Rats and Preserves Affinity for the Serotonin Transporter (SERT) |
| Q34420036 | Behavioral assessment of acute inhibition of system xc (-) in rats |
| Q37971289 | Breaking the loop: oxytocin as a potential treatment for drug addiction. |
| Q34535259 | Clinical applications of hallucinogens: A review |
| Q57176236 | Dark Classics in Chemical Neuroscience: 3,4-Methylenedioxymethamphetamine |
| Q44749162 | Decreased pain tolerance and mood in recreational users of MDMA. |
| Q34500725 | Defensive behavior in rats towards predatory odors: a review |
| Q36660690 | Differential alteration of the effects of MDMA (ecstasy) on locomotor activity and cocaine conditioned place preference in male adolescent rats by social and environmental enrichment |
| Q42598029 | Differential behavioral outcomes of 3,4-methylenedioxymethamphetamine (MDMA-ecstasy) in anxiety-like responses in mice |
| Q34645756 | Dissociation of the neurochemical and behavioral toxicology of MDMA ('Ecstasy') by citalopram |
| Q34675745 | Effects of 3,4-methylenedioxymethamphetamine on socioemotional feelings, authenticity, and autobiographical disclosure in healthy volunteers in a controlled setting |
| Q27329826 | Effects of MDMA Injections on the Behavior of Socially-Housed Long-Tailed Macaques (Macaca fascicularis) |
| Q46399265 | Ethanol, 3,4-methylenedioxymethamphetamine (ecstasy) and their combination: long-term behavioral, neurochemical and neuropharmacological effects in the rat. |
| Q24648383 | From ultrasocial to antisocial: a role for oxytocin in the acute reinforcing effects and long-term adverse consequences of drug use? |
| Q44497121 | Hippocampal serotonergic damage induced by MDMA (ecstasy): effects on spatial learning |
| Q43832354 | Increased anxiety and impaired memory in rats 3 months after administration of 3,4-methylenedioxymethamphetamine ("ecstasy"). |
| Q44050776 | Increased anxiety in rats after 3,4-methylenedioxymethamphetamine: association with serotonin depletion |
| Q43913092 | Induction of hyperlocomotion in mice exposed to a novel environment by inhibition of serotonin reuptake. A pharmacological characterization of diverse classes of antidepressant agents |
| Q42689728 | Inhibiting progesterone metabolism in the hippocampus of rats in behavioral estrus decreases anxiolytic behaviors and enhances exploratory and antinociceptive behaviors |
| Q24630561 | Is ecstasy an "empathogen"? Effects of ±3,4-methylenedioxymethamphetamine on prosocial feelings and identification of emotional states in others |
| Q36979068 | Low doses of the NMDA receptor antagonists, MK-801, PEAQX, and ifenprodil, induces social facilitation in adolescent male rats |
| Q40537975 | MDMA ("ecstasy"), methamphetamine and their combination: long-term changes in social interaction and neurochemistry in the rat. |
| Q37149027 | MDMA (3,4-Methylenedioxymethamphetamine) Analogues as Tools to Characterize MDMA-Like Effects: An Approach to Understand Entactogen Pharmacology |
| Q48369774 | MDMA in adolescent male rats: decreased serotonin in the amygdala and behavioral effects in the elevated plus-maze test |
| Q48844071 | Mephedrone (4-methylmethcathinone, 'meow'): acute behavioural effects and distribution of Fos expression in adolescent rats |
| Q37011117 | Microinjection of muscimol into the dorsomedial hypothalamus suppresses MDMA-evoked sympathetic and behavioral responses. |
| Q46478879 | Neural correlates of MDMA ("Ecstasy")-induced social interaction in rats |
| Q47731855 | Oxytocin and MDMA ('Ecstasy') enhance social reward in rats |
| Q37113859 | Perspectives on zebrafish models of hallucinogenic drugs and related psychotropic compounds |
| Q37900547 | Potential for oxytocin use in children and adolescents with mental illness. |
| Q44784005 | Repeated exposure to MDMA and amphetamine: sensitization, cross-sensitization, and response to dopamine D₁- and D₂-like agonists |
| Q47662199 | Separating the agony from ecstasy: R(-)-3,4-methylenedioxymethamphetamine has prosocial and therapeutic-like effects without signs of neurotoxicity in mice |
| Q42689717 | Testosterone increases analgesia, anxiolysis, and cognitive performance of male rats |
| Q46970778 | The acute and long-term neurotoxic effects of MDMA on marble burying behaviour in mice |
| Q35039457 | The anxiogenic drug yohimbine reinstates palatable food seeking in a rat relapse model: a role of CRF1 receptors |
| Q35146115 | The pre-clinical behavioural pharmacology of 3,4-methylenedioxymethamphetamine (MDMA). |
| Q34495787 | The prosocial effects of 3,4-methylenedioxymethamphetamine (MDMA): Controlled studies in humans and laboratory animals. |
| Q35858540 | Top-Down Control of Serotonin Systems by the Prefrontal Cortex: A Path toward Restored Socioemotional Function in Depression |
| Q36742799 | Treatment with a serotonin-depleting regimen of MDMA prevents conditioned place preference to sex in male rats |
Search more.